TS Financial Group (TSFG)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

TS Financial Group (TSFG)’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-160	Closed	-$2K	–	825
2024 Q1	$2K	Hold	160	–	–	﹤0.01%	693
2023 Q4	$2K	Hold	160	–	–	﹤0.01%	761
2023 Q3	$2K	Hold	160	–	–	﹤0.01%	871
2023 Q2	$2K	Hold	160	–	–	﹤0.01%	868
2023 Q1	$2K	Hold	160	–	–	﹤0.01%	852
2022 Q4	$2K	Hold	160	–	–	﹤0.01%	871
2022 Q3	$1K	Hold	160	–	–	﹤0.01%	944
2022 Q2	$1K	Hold	160	–	–	﹤0.01%	967
2022 Q1	$1K	Hold	160	–	–	﹤0.01%	904
2021 Q4	$1K	Hold	160	–	–	﹤0.01%	876
2021 Q3	$1K	Hold	160	–	–	﹤0.01%	848
2021 Q2	$1K	Hold	160	–	–	﹤0.01%	871
2021 Q1	$1K	Hold	160	–	–	﹤0.01%	747
2020 Q4	$1K	Hold	160	–	–	﹤0.01%	902
2020 Q3	$1K	Hold	160	–	–	﹤0.01%	809
2020 Q2	$1K	Hold	160	–	–	﹤0.01%	849
2020 Q1	$1K	Hold	160	–	–	﹤0.01%	829
2019 Q4	$1K	Hold	160	–	–	﹤0.01%	817
2019 Q3	$1K	Sell	160 -43	-21%	-$215	﹤0.01%	784
2019 Q2	$1K	Hold	203	–	–	﹤0.01%	762
2019 Q1	$1K	Buy	+203	New	+$933	﹤0.01%	786

Other funds holding MACK

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TS Financial Group (TSFG)'s MACK Position: Q2 2024 in Review

TS Financial Group (TSFG) sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 160 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in MACK in Q1 2019 and held it in 21 quarters. The position peaked at $2K in Q1 2024. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

TS Financial Group (TSFG) reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
TS Financial Group (TSFG) sold 160 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $2K.
TS Financial Group (TSFG) first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2019 and held it in 21 quarters.
TS Financial Group (TSFG)'s Merrimack Pharmaceuticals, Inc. position peaked at $2K in Q1 2024.
12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2024, filed 16 Jul 2024.